期刊
BMC BIOINFORMATICS
卷 24, 期 1, 页码 -出版社
BMC
DOI: 10.1186/s12859-023-05489-5
关键词
Gene fusion; Fusion transcript; RNA sequencing; Whole-genome sequencing; Breast cancer
This article presents a method for validating fusion transcripts detected by RNA sequencing in matched whole-genome sequencing data. The pipeline uses discordant read pairs and soft-clipped read alignments to identify supported fusion events and determine genomic breakpoints. The method is faster and more sensitive than commonly used structural variant detection software BreakDancer and Manta.
BackgroundIn cancer, genomic rearrangements can create fusion genes that either combine protein-coding sequences from two different partner genes or place one gene under the control of the promoter of another gene. These fusion genes can act as oncogenic drivers in tumor development and several fusions involving kinases have been successfully exploited as drug targets. Expressed fusions can be identified in RNA sequencing (RNA-Seq) data, but fusion prediction software often has a high fraction of false positive fusion transcript predictions. This is problematic for both research and clinical applications.ResultsWe describe a method for validation of fusion transcripts detected by RNA-Seq in matched whole-genome sequencing (WGS) data. Our pipeline uses discordant read pairs to identify supported fusion events and analyzes soft-clipped read alignments to determine genomic breakpoints. We have tested it on matched RNA-Seq and WGS data for both tumors and cancer cell lines and show that it can be used to validate both new predicted gene fusions and experimentally validated fusion events. It was considerably faster and more sensitive than using BreakDancer and Manta, software that is instead designed to detect many different types of structural variants on a genome-wide scale.ConclusionsWe have developed a fast and very sensitive pipeline for validation of gene fusions detected by RNA-Seq in matched WGS data. It can be used to identify high-quality gene fusions for further bioinformatic and experimental studies, including validation of genomic breakpoints and studies of the mechanisms that generate fusions. In a clinical setting, it could help find expressed gene fusions for personalized therapy.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据